Coronavirus COVID-19 News specific to South Africa

Nicholas

Well-Known Member
Joined
Jun 23, 2020
Messages
6,463
Location
East London

biometrics

Well-Known Member
Joined
Oct 17, 2019
Messages
20,354
Overstrand active cases (Kleinmond, Hermanus, Stanford and Gansbaai)

27 Nov 41
29 Nov 64
7 Dec 98
9 Dec 122
11 Dec 138
14 Dec 207
17 Dec 287
18 Dec 314
21 Dec 376
23 Dec 481
24 Dec 559
28 Dec 661
30 Dec 623
31 Dec 748
4 Jan 733
6 Jan 678
8 Jan 734
11 Jan 507
14 Jan 656
18 Jan 759
20 Jan 511
22 Jan 482
25 Jan 478
27 Jan 418
29 Jan 422
1 Feb 160
3 Feb 161
8 Feb 123
10 Feb 114
12 Feb 105
15 Feb 82
19 Feb 68
24 Feb 67
26 Feb 65
5 Mar 49
 

biometrics

Well-Known Member
Joined
Oct 17, 2019
Messages
20,354
Now the results of a trial published in the prestigious Journal of American Medical Association (JAMA) should strengthen Sahpra’s arm in its legal battles. Among 398 adults with mild Covid-19, a five-day course of ivermectin compared with a placebo, did not significantly improve symptoms.

This was a double-blind, randomised trial. In other words, neither the participants nor the researchers knew who was receiving ivermectin or a placebo until the trial was finished. It is the first such study with published peer-reviewed results. (A trial with inconclusive results was published in The Lancet a few weeks ago but it only had 24 participants.)

The findings don’t support the use of ivermectin for treatment of mild Covid-19, although larger trials may be needed to understand the effects of ivermectin on other clinically relevant outcomes, the researchers concluded.

 

biometrics

Well-Known Member
Joined
Oct 17, 2019
Messages
20,354
Overstrand active cases (Kleinmond, Hermanus, Stanford and Gansbaai)

27 Nov 41
29 Nov 64
7 Dec 98
9 Dec 122
11 Dec 138
14 Dec 207
17 Dec 287
18 Dec 314
21 Dec 376
23 Dec 481
24 Dec 559
28 Dec 661
30 Dec 623
31 Dec 748
4 Jan 733
6 Jan 678
8 Jan 734
11 Jan 507
14 Jan 656
18 Jan 759
20 Jan 511
22 Jan 482
25 Jan 478
27 Jan 418
29 Jan 422
1 Feb 160
3 Feb 161
8 Feb 123
10 Feb 114
12 Feb 105
15 Feb 82
19 Feb 68
24 Feb 67
26 Feb 65
5 Mar 49
8 Mar 40
 

biometrics

Well-Known Member
Joined
Oct 17, 2019
Messages
20,354
Overstrand active cases (Kleinmond, Hermanus, Stanford and Gansbaai)

27 Nov 41
29 Nov 64
7 Dec 98
9 Dec 122
11 Dec 138
14 Dec 207
17 Dec 287
18 Dec 314
21 Dec 376
23 Dec 481
24 Dec 559
28 Dec 661
30 Dec 623
31 Dec 748
4 Jan 733
6 Jan 678
8 Jan 734
11 Jan 507
14 Jan 656
18 Jan 759
20 Jan 511
22 Jan 482
25 Jan 478
27 Jan 418
29 Jan 422
1 Feb 160
3 Feb 161
8 Feb 123
10 Feb 114
12 Feb 105
15 Feb 82
19 Feb 68
24 Feb 67
26 Feb 65
5 Mar 49
8 Mar 40
12 Mar 40
 

bigAl-sa

Well-Known Member
Joined
May 10, 2020
Messages
1,130
Location
Dros
I see Google has forced Eskom se Push to withdraw their daily SA corona scorecard:

It was a very useful digest of what was going on.

Methinks Google is getting way too big for its britches.
 

biometrics

Well-Known Member
Joined
Oct 17, 2019
Messages
20,354
I see Google has forced Eskom se Push to withdraw their daily SA corona scorecard:

It was a very useful digest of what was going on.

Methinks Google is getting way too big for its britches.
They recently forced me to remove GPS tracking from an app and when I published it was forced to use the latest SDK 29 which don’t allow access to the directory we used for years forcing changes and an enforced update procedure for users as to not lose data. Google really pisses me off, almost as much as Apple. These companies don’t give a shit what their constant changes do to developers.
 
Last edited:

biometrics

Well-Known Member
Joined
Oct 17, 2019
Messages
20,354

biometrics

Well-Known Member
Joined
Oct 17, 2019
Messages
20,354
Overstrand active cases (Kleinmond, Hermanus, Stanford and Gansbaai)

27 Nov 41
29 Nov 64
7 Dec 98
9 Dec 122
11 Dec 138
14 Dec 207
17 Dec 287
18 Dec 314
21 Dec 376
23 Dec 481
24 Dec 559
28 Dec 661
30 Dec 623
31 Dec 748
4 Jan 733
6 Jan 678
8 Jan 734
11 Jan 507
14 Jan 656
18 Jan 759
20 Jan 511
22 Jan 482
25 Jan 478
27 Jan 418
29 Jan 422
1 Feb 160
3 Feb 161
8 Feb 123
10 Feb 114
12 Feb 105
15 Feb 82
19 Feb 68
24 Feb 67
26 Feb 65
5 Mar 49
8 Mar 40
12 Mar 40
15 Mar 35

Under 40, excellent.
 
Top